SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001385508-23-000036
Filing Date
2023-02-07
Accepted
2023-02-07 16:26:16
Documents
15
Period of Report
2023-02-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K opnt-20230202.htm   iXBRL 8-K 57838
2 EX-99.1 opntpressrelease_hsrapprov.htm EX-99.1 19093
3 EX-99.2 opntpressrelease_cfiusappr.htm EX-99.2 21224
  Complete submission text file 0001385508-23-000036.txt   295077

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opnt-20230202.xsd EX-101.SCH 2150
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT opnt-20230202_def.xml EX-101.DEF 15433
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opnt-20230202_lab.xml EX-101.LAB 29833
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opnt-20230202_pre.xml EX-101.PRE 16094
9 EXTRACTED XBRL INSTANCE DOCUMENT opnt-20230202_htm.xml XML 14561
Mailing Address 233 WILSHIRE BLVD SUITE 400 SANTA MONICA CA 90401
Business Address 233 WILSHIRE BLVD SUITE 400 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 464744124 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38193 | Film No.: 23595417
SIC: 2834 Pharmaceutical Preparations